Aspen Aerogels (NYSE: ASPN) reported Q3 EPS of ($0.27), $0.03 worse than the analyst estimate of ($0.24). Revenue for the quarter came in at $23.9 million versus the consensus estimate of $26.11 million.

For earnings history and earnings-related data on Aspen Aerogels (ASPN) click here.